Sansure Biotech Inc. (SHA:688289)
14.36
+0.17 (1.20%)
Jun 18, 2026, 11:30 AM CST
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 8.16 billion as of June 17, 2026. Its market cap has decreased by -29.63% in one year.
Market Cap
8.16B
Enterprise Value
5.48B
Revenue
1.60B
Ranking
n/a
PE Ratio
54.00
Stock Price
14.36
Market Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 8.16B, a decrease of -82.43%. That is a compound annual growth rate of -25.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 8.23B | -24.18% |
| Dec 31, 2025 | 10.86B | -16.48% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autek China | 10.13B |
| Tofflon Science and Technology Group | 8.73B |
| Tinavi Medical Technologies | 8.26B |
| Eyebright Medical Technology (Beijing) | 7.74B |
| Aidite (Qinhuangdao) Technology | 6.48B |
| Mingyue Optical Lens | 6.07B |
| Truking Technology | 5.81B |
| Blue Sail Medical | 5.75B |